Martin Shkreli, the former hedge fund manager known as "Pharma Bro," defended Palantir Technologies Inc.'s valuation on Tuesday amid the company's surging stock price, projecting substantial cash flow ...

You can't spell gains without "AI" In the fourth quarter, Palantir generated revenue that accelerated to 36% year over year ...

Palantir Technologies stock closed at its highest level on record after the company posted a big beat with its fourth-quarter ...

Calm returned to Wall Street, and tech stocks led U.S. indexes higher after a strong profit report from Palantir Technologies ...

The stock market shrugged off the latest tariff jitters on Tuesday as Wall Street turned its attention back to earnings season. The Dow Jones Industrial Average rose 134 points, or 0.3%. The S&P 500 ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Palantir Technologies Inc. posts strong growth but stock compensation impacts earnings. Click for this PLTR earnings update.

The company’s commercial revenue increased 64% in the quarter while U.S. government sales rose 45%. But if Wall Street ...

Seemingly, the PLTR stock is now in overvalued territory at a forward price-to-earnings (P/E) ratio of 172.41, with an ...

Palantir Technologies’ PLTR outstanding fourth-quarter results, rapid growth amid the artificial intelligence arms race, and ...